David A. Siegel Twist Bioscience Corp Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q3 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Twist Bioscience Corp stock. As of the latest transaction made, Two Sigma Advisers, LP holds 280,500 shares of TWST stock, worth $13 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
280,500
Previous 340,000
17.5%
Holding current value
$13 Million
Previous $16.8 Million
24.37%
% of portfolio
0.03%
Previous 0.04%
Shares
20 transactions
Others Institutions Holding TWST
# of Institutions
258Shares Held
66.6MCall Options Held
127KPut Options Held
45.4K-
Artisan Partners Limited Partnership Milwaukee, WI6.02MShares$280 Million0.43% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.62MShares$261 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.42MShares$252 Million0.01% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.36MShares$249 Million2.3% of portfolio
-
Invesco Ltd. Atlanta, GA3.64MShares$169 Million0.03% of portfolio
About Twist Bioscience Corp
- Ticker TWST
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 56,363,500
- Market Cap $2.62B
- Description
- Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...